green
Positive treatment
8.1 score
Top citers, strongest first. 4 distinct citers.
How cited ↗
discussed
Cited as authority (rule)
Vaught IV v. Oppedisano
(2×)
also: Cited "see, e.g."
First, the deprivation alleged must be, 6 objectively, “sufficiently serious,” Wilson [v. Seiter, supra, 501 U.S., at 298, 7 111 S.Ct., at 2324; see also Hudson v. McMillian, supra, 503 U.S., at 5, 112 S.Ct., at 998; a prison official’s act or omission must result in the denial of 8 “the minimal civilized measure of life’s necessities,” Rhodes [v. Chapman, 9 supra, 452 U.S., at 347 , 101 S.Ct., at 2399 . . . . [¶] The second requirement follows from the principle that “only the unnecessary and wanton infliction of 10 pain implicates the Eighth Amendment.” Wilson, 501 U.S., at …
discussed
Cited as authority (rule)
(PC) Barbour v. United States
The focus of the inquiry is not on the agent’s subjective intent in exercising the 9 discretion conferred by statute or regulation, but on the nature of the actions taken and on whether 10 they are susceptible to policy analysis.” United States v. Gaubert, 499 U.S. 315, 325 , 111 S.Ct. 11 1267, 113 L.Ed.2d 335 (1991).
cited
Cited as authority (rule)
Martinez v. Hacker-Agnew
Coleman, 501 U.S. at 728 , 111 S. Ct. 11 at 2254.
discussed
Cited "see"
Glaxo Wellcome, Inc. v. Pharmadyne Corp.
See generally Eli Lilly and Co. v. Medtronic, Inc., 496 U.S. 661, 676 , 110 S.Ct. 2683 , 110 L.Ed.2d 605 , reh’g denied, 497 U.S. 1047 , 111 S.Ct. 11 , 111 L.Ed.2d 825 (1990); Glaxo v. Novopharm, Ltd., 110 F.3d 1562, 1568-69 (Fed.Cir.1997), aff'g, 931 F.Supp. 1280 (E.D.N.C.1996).
Retrieving the full opinion text from the archive…
Chambers
v.
Office of Federal Contract Compliance Programs
v.
Office of Federal Contract Compliance Programs
No. 89-6285.
Supreme Court of the United States.
Aug 13, 1990.
Published
494 U. S. 1032. Motion for leave to file petition for rehearing denied.